Sagimet Biosciences (SGMT) Net Cash Flow: 2023-2024
Historic Net Cash Flow for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to -$18.9 million.
- Sagimet Biosciences' Net Cash Flow fell 122.73% to -$18.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$24.8 million, marking a year-over-year change of. This contributed to the annual value of $701,000 for FY2024, which is 99.07% down from last year.
- Latest data reveals that Sagimet Biosciences reported Net Cash Flow of -$18.9 million as of Q3 2024, which was up 76.56% from -$80.8 million recorded in Q2 2024.
- Sagimet Biosciences' Net Cash Flow's 5-year high stood at $101.6 million during Q1 2024, with a 5-year trough of -$80.8 million in Q2 2024.
- In the last 2 years, Sagimet Biosciences' Net Cash Flow had a median value of $6.2 million in 2023 and averaged $11.0 million.
- Within the past 5 years, the most significant YoY rise in Sagimet Biosciences' Net Cash Flow was 734.47% (2024), while the steepest drop was 1,409.85% (2024).
- Over the past 2 years, Sagimet Biosciences' Net Cash Flow (Quarterly) stood at -$26.7 million in 2023, then tumbled by 122.73% to -$18.9 million in 2024.
- Its last three reported values are -$18.9 million in Q3 2024, -$80.8 million for Q2 2024, and $101.6 million during Q1 2024.